Market Research Reports

Price range (USD)
$450 up to $22,000

Strategic Intelligence & Industry Research

Explore our library of analyst-validated market research reports. Our intelligence covers critical industry trends, competitive landscapes, and data-driven market forecasts to support your strategic decision-making.

Can’t find the report you need? If our syndicated library doesn’t have the precise data point or scope you are looking for, we provide custom research services designed to deliver the exact intelligence your organization requires.

Displaying 37 - 48 of 190 reports match your search
Navadhi Market Research · Pharmaceuticals
On demand

India Biopharmaceutical CDMO Market Strategic Research Report

India's biopharmaceutical contract development and manufacturing organization (CDMO) market has emerged as one of the most consequential segments within the country'…

$3.8B
2025
$9.1B
2032
▲ 13.2%CAGR2025–2032
13.2% CAGR $3.8B em 2025 India
US$ 1.495,00 from
Forecast $9.1B by 2032
View report
Navadhi Market Research · Pharmaceuticals
Publicado

Global Peptide Market Strategic Intelligence Suite

The Global Peptide Market Strategic Intelligence Suite 2026–2031 is Navadhi Market Research's most comprehensive intelligence offering on the global peptide industry…

$84.2B
2024
$252.9B
2032
▲ 14.74%CAGR2024–2032
14.74% CAGR $84.2B em 2024 551 pages Global
US$ 11.000,00 from
Forecast $252.9B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global KRAS G12C and Pan-KRAS Inhibitors Market Strategic Research Report

The global KRAS G12C and Pan-KRAS inhibitors market represents one of the most consequential frontiers in targeted oncology therapeutics, addressing mutations in the…

$2.8B
2025
$11.8B
2032
▲ 22.8%CAGR2025–2032
22.8% CAGR $2.8B em 2025 Global
US$ 3.500,00 from
Forecast $11.8B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Anticoagulants Market Strategic Research Report

The global anticoagulants market represents one of the most clinically critical and commercially consequential segments within the cardiovascular pharmaceutical land…

$28.4B
2025
$44.7B
2032
▲ 6.7%CAGR2025–2032
6.7% CAGR $28.4B em 2025 150 pages Global
US$ 3.500,00 from
Forecast $44.7B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Congenital Hyperinsulinism Treatment Market Strategic Research Report

Congenital hyperinsulinism (CHI) is the most common cause of persistent hypoglycemia in neonates and infants, arising from genetic defects in pancreatic beta-cell re…

$870
2025
$1783.6
2032
▲ 10.8%CAGR2025–2032
10.8% CAGR $870 em 2025 150 pages Global
US$ 3.500,00 from
Forecast $1783.6 by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Oral GLP-1 Receptor Agonists Market Strategic Research Report

The global oral GLP-1 receptor agonist market sits at the intersection of one of medicine's most consequential therapeutic shifts and a decades-long unmet patient ne…

$4.8B
2025
$29.6B
2032
▲ 29.7%CAGR2025–2032
29.7% CAGR $4.8B em 2025 Global
US$ 3.500,00 from
Forecast $29.6B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Next-Generation Dual and Triple Incretin Agonists Market Strategic Research Report

The global next-generation dual and triple incretin agonist market represents one of the most consequential therapeutic inflection points in modern endocrinology and…

$28.4B
2025
$119.6B
2032
▲ 22.8%CAGR2025–2032
22.8% CAGR $28.4B em 2025 Global
US$ 3.500,00 from
Forecast $119.6B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Matrix-Metalloproteinase Inhibitor Targeted Therapeutics Market Strategic Research Report

The global matrix-metalloproteinase (MMP) inhibitor targeted therapeutics market represents one of oncology and inflammatory disease research's most consequential fr…

$2.8B
2025
$5.2B
2032
▲ 9.1%CAGR2025–2032
9.1% CAGR $2.8B em 2025 Global
US$ 3.500,00 from
Forecast $5.2B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Menstrual Bleeding Disorders Novel Therapeutics Market Strategic Research Report

The global menstrual bleeding disorders novel therapeutics market represents one of the most underserved and commercially consequential segments within women's healt…

$4.8B
2025
$8.6B
2032
▲ 8.6%CAGR2025–2032
8.6% CAGR $4.8B em 2025 Global
US$ 3.500,00 from
Forecast $8.6B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Microbiome-Based Therapeutics and Live Biotherapeutic Products Market Strategic Research Report

The global microbiome-based therapeutics and live biotherapeutic products (LBPs) market represents one of the most scientifically consequential frontiers in modern m…

$1.4B
2025
$5.8B
2032
▲ 22.5%CAGR2025–2032
22.5% CAGR $1.4B em 2025 Global
US$ 3.500,00 from
Forecast $5.8B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Postmenopausal Osteoporosis Market Strategic Research Report

The global postmenopausal osteoporosis market represents one of the most commercially significant segments within women's health and skeletal disease therapeutics. D…

$12.4B
2025
$18.9B
2032
▲ 6.2%CAGR2025–2032
6.2% CAGR $12.4B em 2025 150 pages Global
US$ 3.500,00 from
Forecast $18.9B by 2032
View report
Navadhi Market Research · Pharmaceuticals
On demand

Global Osteoporosis Drugs Market Strategic Research Report

The global osteoporosis drugs market represents one of the most commercially significant segments within the musculoskeletal therapeutics space, underpinned by the a…

$15.8B
2025
$24.7B
2032
▲ 6.6%CAGR2025–2032
6.6% CAGR $15.8B em 2025 150 pages Global
US$ 3.500,00 from
Forecast $24.7B by 2032
View report